AstraZeneca To Make Seroquel Label Changes
At the request of federal regulators, AstraZeneca Pharmaceuticals LP has agreed to modify the warning label on its blockbuster anti-psychotic medication Seroquel to make information about potential health risks more prominent....To view the full article, register now.
Already a subscriber? Click here to view full article